Annual CFF
$27.54 M
+$28.01 M+5947.35%
December 31, 2023
Summary
- As of March 13, 2025, UNCY annual cash flow from financing activities is $27.54 million, with the most recent change of +$28.01 million (+5947.35%) on December 31, 2023.
- During the last 3 years, UNCY annual CFF has risen by +$26.10 million (+1807.27%).
- UNCY annual CFF is now at all-time high.
Performance
UNCY Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$157.00 K
+$654.00 K+80.64%
September 30, 2024
Summary
- As of March 13, 2025, UNCY quarterly cash flow from financing activities is -$157.00 thousand, with the most recent change of +$654.00 thousand (+80.64%) on September 30, 2024.
- Over the past year, UNCY quarterly CFF has increased by +$48.00 thousand (+23.41%).
- UNCY quarterly CFF is now -100.34% below its all-time high of $45.69 million, reached on March 31, 2024.
Performance
UNCY Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$44.52 M
-$106.00 K-0.24%
September 30, 2024
Summary
- As of March 13, 2025, UNCY TTM cash flow from financing activities is $44.52 million, with the most recent change of -$106.00 thousand (-0.24%) on September 30, 2024.
- Over the past year, UNCY TTM CFF has increased by +$16.98 million (+61.64%).
- UNCY TTM CFF is now -2.02% below its all-time high of $45.44 million, reached on March 31, 2024.
Performance
UNCY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
UNCY Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5947.4% | +23.4% | +61.6% |
| 3 y3 years | +1807.3% | +23.4% | +61.6% |
| 5 y5 years | +2262.0% | +23.4% | +61.6% |
UNCY Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5947.4% | -100.3% | +80.6% | -2.0% | +9551.8% |
| 5 y | 5-year | at high | +5947.4% | -100.3% | +80.6% | -2.0% | +9551.8% |
| alltime | all time | at high | +5947.4% | -100.3% | +80.6% | -2.0% | +9551.8% |
Unicycive Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$157.00 K(-80.6%) | $44.52 M(-0.2%) |
| Jun 2024 | - | -$811.00 K(-101.8%) | $44.62 M(-1.8%) |
| Mar 2024 | - | $45.69 M(<-9900.0%) | $45.44 M(+65.0%) |
| Dec 2023 | $27.54 M(-5947.3%) | -$205.00 K(+302.0%) | $27.54 M(+1.0%) |
| Sep 2023 | - | -$51.00 K(<-9900.0%) | $27.27 M(-0.2%) |
| Jun 2023 | - | $0.00(-100.0%) | $27.33 M(0.0%) |
| Mar 2023 | - | $27.80 M(-6001.7%) | $27.33 M(-5901.7%) |
| Dec 2022 | -$471.00 K | -$471.00 K(<-9900.0%) | -$471.00 K(<-9900.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2022 | - | $0.00(0.0%) | $21.48 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(0.0%) | $21.55 M(-3.7%) |
| Dec 2021 | $22.38 M(+1449.5%) | $0.00(-100.0%) | $22.38 M(-2.1%) |
| Sep 2021 | - | $21.48 M(>+9900.0%) | $22.85 M(+970.8%) |
| Jun 2021 | - | $71.00 K(-91.3%) | $2.13 M(-3.2%) |
| Mar 2021 | - | $820.00 K(+72.6%) | $2.20 M(+52.6%) |
| Dec 2020 | $1.44 M(+23.8%) | - | - |
| Dec 2020 | - | $475.00 K(-38.2%) | $1.44 M(+49.0%) |
| Sep 2020 | - | $768.00 K(+444.7%) | $969.00 K(+382.1%) |
| Jun 2020 | - | $141.00 K(+135.0%) | $201.00 K(+235.0%) |
| Mar 2020 | - | $60.00 K | $60.00 K |
| Dec 2019 | $1.17 M | - | - |
FAQ
- What is Unicycive Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Unicycive Therapeutics?
- What is Unicycive Therapeutics annual CFF year-on-year change?
- What is Unicycive Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Unicycive Therapeutics?
- What is Unicycive Therapeutics quarterly CFF year-on-year change?
- What is Unicycive Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Unicycive Therapeutics?
- What is Unicycive Therapeutics TTM CFF year-on-year change?
What is Unicycive Therapeutics annual cash flow from financing activities?
The current annual CFF of UNCY is $27.54 M
What is the all time high annual CFF for Unicycive Therapeutics?
Unicycive Therapeutics all-time high annual cash flow from financing activities is $27.54 M
What is Unicycive Therapeutics annual CFF year-on-year change?
Over the past year, UNCY annual cash flow from financing activities has changed by +$28.01 M (+5947.35%)
What is Unicycive Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of UNCY is -$157.00 K
What is the all time high quarterly CFF for Unicycive Therapeutics?
Unicycive Therapeutics all-time high quarterly cash flow from financing activities is $45.69 M
What is Unicycive Therapeutics quarterly CFF year-on-year change?
Over the past year, UNCY quarterly cash flow from financing activities has changed by +$48.00 K (+23.41%)
What is Unicycive Therapeutics TTM cash flow from financing activities?
The current TTM CFF of UNCY is $44.52 M
What is the all time high TTM CFF for Unicycive Therapeutics?
Unicycive Therapeutics all-time high TTM cash flow from financing activities is $45.44 M
What is Unicycive Therapeutics TTM CFF year-on-year change?
Over the past year, UNCY TTM cash flow from financing activities has changed by +$16.98 M (+61.64%)